Table 3. Quality assessment of the studies using ARRIVE guidelines.
| ARRIVE checklist items | Hastur et al. (2006) [30] | Hasturk et al. (2007) [29] | Hasturk et al. (2015) [28] | Lee et al. (2016) [31] | Mizraji et al. (2018) [32] |
| Abstract | 1 | 1 | 1 | 1 | 1 |
| Background | 1 | 1 | 1 | 1 | 1 |
| Objectives | 1 | 1 | 1 | 1 | 1 |
| Ethical statement | 0 | 0 | 0 | 0 | 1 |
| Experimental animals | 1 | 1 | 1 | 1 | 1 |
| Housing/Husbandry | 1 | 1 | 1 | 1 | 1 |
| Experimental procedures | 1 | 1 | 1 | 1 | 1 |
| Animal care and monitoring | 1 | 1 | 1 | 1 | 1 |
| Outcomes measures | 1 | 1 | 1 | 1 | 1 |
| Inclusion and exclusion criteria | 0 | 0 | 0 | 0 | 0 |
| Study design | 1 | 1 | 1 | 1 | 1 |
| Randomization | 1 | 1 | 1 | 1 | 0 |
| Blinding | 0 | 0 | 0 | 0 | 0 |
| Sample size | 1 | 1 | 1 | 1 | 1 |
| Statistical methods | 1 | 1 | 1 | 1 | 1 |
| Protocol registration | 1 | 1 | 1 | 1 | 1 |
| Results | 1 | 1 | 1 | 1 | 1 |
| Data access | 0 | 0 | 1 | 1 | 1 |
| Interpretation/scientific implications | 1 | 1 | 1 | 1 | 1 |
| Generalizability | 1 | 1 | 1 | 1 | 1 |
| Declaration of Interest | 0 | 1 | 1 | 1 | 1 |
| Scoring | 16 | 17 | 18 | 18 | 18 |